Atara Biotherapeutics, Inc. - COM (ATRA)

Historical Portfolio Holders from Q4 2014 to Q1 2024

All holders as of March 31, 2024: Q1 2024
Type / Class: Equity / COM
Shares, excl. options Q1 2024: 80.9 M
Holdings value Q1 2024: $56.1 M
Value change Q1 2024: +$13.7 M
Grand Portfolio weight change Q1 2024: +0%
Number of holders: 75
Number of buys Q1 2024: 38
Number of sells Q1 2024: -50
Average buys Q1 2024 %: +0%
Average sells Q1 2024 %: 0%
CUSIP: 046513107

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

Period	Shares, Excl. Options	Value, Excl. Options	Change	Puts Notional Value	Calls Notional Value	Price	Investors
2024 Q1	80.9 M	$56.1 M	+$13.7 M	35.6 K	12.8 K	$0.69	75
2023 Q4	62.6 M	$32.1 M	-$40.3 M	103	4.87 K	$0.51	87
2023 Q3	85.1 M	$126 M	-$2.7 M	69.9 K	1.41 M	$1.48	104
2023 Q2	89.6 M	$144 M	-$26 M	22.1 K	1.54 M	$1.61	110
2023 Q1	102 M	$297 M	+$14.4 M	16.5 K	3.01 M	$2.90	120
2022 Q4	97.2 M	$319 M	-$2.3 M	22.3 K	2.71 M	$3.28	133
2022 Q3	90.2 M	$341 M	-$18.5 M		88 K	$3.78	141
2022 Q2	87.6 M	$682 M	+$4.02 M		519 K	$7.79	125
2022 Q1	97.8 M	$909 M	+$12.5 M	0	1.31 M	$9.29	137
2021 Q4	92.5 M	$1.46 B	+$80.4 M	167 K	876 K	$15.76	130
2021 Q3	87.8 M	$1.57 B	+$68.6 M	288 K	464 K	$17.90	135
2021 Q2	84.1 M	$1.31 B	+$14.8 M	425 K	359 K	$15.55	141
2021 Q1	86.1 M	$1.24 B	-$11.3 M	281 K	939 K	$14.36	146
2020 Q4	82.4 M	$1.62 B	+$50.6 M	1.62 M	1.25 M	$19.63	139
2020 Q3	82.4 M	$1.07 B	+$62.3 M	614 K	1.47 M	$12.96	131
2020 Q2	76.4 M	$1.11 B	+$284 M	699 K	1.15 M	$14.57	115
2020 Q1	59.7 M	$507 M	+$1.17 M	235 K	540 K	$8.51	100
2019 Q4	58.2 M	$958 M	+$38.7 M	1.92 M	807 K	$16.47	109
2019 Q3	56 M	$791 M	+$105 M	997 K	2.15 M	$14.12	105
2019 Q2	50.3 M	$1.01 B	+$23.2 M	1.28 M	3.13 M	$20.11	111
2019 Q1	48.8 M	$1.94 B	+$25 M	1.9 M	7.09 M	$39.75	115
2018 Q4	48.2 M	$1.68 B	+$62.6 M	1.38 M	4.56 M	$34.74	120
2018 Q3	46.3 M	$1.92 B	-$3.17 M	4.64 M	2.3 M	$41.35	115
2018 Q2	46.5 M	$1.71 B	+$111 M	11.3 M	13 M	$36.75	121
2018 Q1	43.4 M	$1.69 B	+$555 M	5.18 M	31.4 M	$39.00	114
2017 Q4	29.8 M	$541 M	+$34.9 M	1.94 M	738 K	$18.10	82
2017 Q3	26.6 M	$441 M	+$15.3 M	0	452 K	$16.55	80
2017 Q2	25.7 M	$360 M	+$19.5 M	801 K	1.43 M	$14.00	79
2017 Q1	24 M	$493 M	+$57 M	251 K	528 K	$20.55	81
2016 Q4	23.2 M	$329 M	+$7.52 M			$14.20	81
2016 Q3	22.4 M	$479 M	+$15.4 M			$21.39	70
2016 Q2	21.6 M	$486 M	+$46.7 M			$22.51	68
2016 Q1	19.8 M	$377 M	+$7.11 M	0	0	$19.03	68
2015 Q4	19.3 M	$509 M	-$20.9 M	1.73 M	728 K	$26.41	84
2015 Q3	19.5 M	$612 M	+$193 M	1.26 M	1.46 M	$31.44	85
2015 Q2	13.1 M	$691 M	+$108 M	1.36 M	543 K	$52.76	74
2015 Q1	11.2 M	$462 M	+$186 M			$41.57	52
2014 Q4	6.73 M	$172 M	+$162 M			$26.75	39